Published • loading... • Updated
Eli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030
Summary by 24/7 Wall St.
2 Articles
2 Articles
24/7 Wall St.Reposted by 
BizToc
BizTocEli Lilly Vs. Merck: One is a No-Brainer to Hold Through 2030
Eli Lilly and Merck both reported second quarter earnings, and the contrast could not be sharper. One company is compounding a franchise that keeps widening, while the other is racing to patch a hole before a patent cliff arrives.
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
![[Opinion] AI-Focused Company Anthropic Starts Operating a Biological Laboratory - Seznam Zprávy](/_next/image?url=https%3A%2F%2Fgrnd.b-cdn.net%2Finterests%2Fbcc24b7060085d1ebc4db4e6b8d92c71c3ca0c91.jpg&w=1440&q=75)
